Triple
T21818435
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Max Planck Society Biology and Medicine Section |
E538660
|
entity |
| Predicate | oversees |
P46
|
FINISHED |
| Object | Max Planck Institutes for Molecular Biomedicine |
—
|
NE NERFINISHED |
Disambiguation candidates (2 decisions)
The exact options the model was shown at each disambiguation step, with the option it chose highlighted — the evidence behind this triple's disambiguated ids.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Max Planck Institutes for Molecular Biomedicine Context triple: [Max Planck Society Biology and Medicine Section, oversees, Max Planck Institutes for Molecular Biomedicine]
-
A.
Max Planck Institute for Experimental Medicine
The Max Planck Institute for Experimental Medicine is a German research institute in Göttingen that conducts advanced biomedical and neuroscience research as part of the Max Planck Society.
-
B.
Max Planck Institutes for biological research
The Max Planck Institutes for biological research are a group of German research institutes renowned for pioneering basic research in fields such as molecular biology, genetics, neuroscience, and biochemistry under the Max Planck Society.
-
C.
Max Planck Institutes for Immunobiology and Epigenetics
The Max Planck Institutes for Immunobiology and Epigenetics are German research institutes dedicated to fundamental studies of the immune system and epigenetic regulation, operating under the Max Planck Society.
-
D.
Max Planck Institute for Biophysics
The Max Planck Institute for Biophysics is a leading German research institute in Frankfurt dedicated to fundamental studies of the physical principles underlying biological systems, particularly the structure and function of biomolecules and membranes.
-
E.
Max Planck Institute for Biophysical Chemistry
The Max Planck Institute for Biophysical Chemistry is a leading German research institute in Göttingen that conducts interdisciplinary fundamental research at the interface of biology, chemistry, and physics.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Max Planck Institutes for Molecular Biomedicine Target entity description: The Max Planck Institutes for Molecular Biomedicine are German research institutes dedicated to advancing fundamental understanding of molecular and cellular mechanisms underlying development, disease, and tissue regeneration.
-
A.
Max Planck Institute for Experimental Medicine
The Max Planck Institute for Experimental Medicine is a German research institute in Göttingen that conducts advanced biomedical and neuroscience research as part of the Max Planck Society.
-
B.
Max Planck Institutes for biological research
The Max Planck Institutes for biological research are a group of German research institutes renowned for pioneering basic research in fields such as molecular biology, genetics, neuroscience, and biochemistry under the Max Planck Society.
-
C.
Max Planck Institutes for Immunobiology and Epigenetics
The Max Planck Institutes for Immunobiology and Epigenetics are German research institutes dedicated to fundamental studies of the immune system and epigenetic regulation, operating under the Max Planck Society.
-
D.
Max Planck Institute for Biophysics
The Max Planck Institute for Biophysics is a leading German research institute in Frankfurt dedicated to fundamental studies of the physical principles underlying biological systems, particularly the structure and function of biomolecules and membranes.
-
E.
Max Planck Institute for Biophysical Chemistry
The Max Planck Institute for Biophysical Chemistry is a leading German research institute in Göttingen that conducts interdisciplinary fundamental research at the interface of biology, chemistry, and physics.
- F. None of above. chosen
Provenance (2 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69e0c475038c8190abb9b1a20eb8ff50 |
elicitation | completed |
| NER | batch_69f07ccd0d908190a43af4fcc7d6ca03 |
ner | completed |
Created at: April 16, 2026, 6:54 p.m.